Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Ayurcann expansion continues with partnership to supply and manufacture products for Joints Cannabis

The company will supply CBD distillate, isolate, and THC distillate to Joint Cannabis for their health and wellbeing products

Ayurcann Holdings Corp (CSE:AYUR) announced that it has struck a supply and manufacturing agreement with Joints Cannabis to supply CBD distillate, Isolate and THC distillate for its health and wellbeing products.

Toronto-based Ayurcann which is a one-stop-shop for Canadian-licensed producers seeking a branded product solution, noted that Joints Cannabis has “market-leading CBD products” like THC-free Repose T-Free Oils, balanced Recess 1:1 Oils and their full spectrum Respite CBD Oils. The products are available in Ontario through authorized retailers and the Ontario Cannabis Store website.

“We are pleased to announce this new relationship. We see this as another step in our continued expansion across Canada with this premier brand,” Ayurcann Chairman and CEO Igal Sudman said in a statement.

READ: Ayurcann Holdings sees quarterly revenue grow to C$2.6M in "milestone" fiscal 3Q

“This arrangement will ensure Joints Cannabis also continues to grow as they realize an expanded reach provided by our connections to market leaders. I have no doubt moving forward both companies will see substantial growth from the partnership.”

Sudman noted that the market is currently filled by “a patchwork” of distributors and manufacturers. “With mutually beneficial arrangements, like the one with Joints Cannabis, we can create structures that ensure high-quality products are available for consumers across the country at a reasonable price point,” added Sudman.

Ayurcann demonstrates the value of industry partnerships with millions of dollars in products manufactured and delivered. The company said it is focused on becoming “the partner of choice” for leading Canadian cannabis brands by providing proprietary services, including ethanol extraction, formulation, product development and custom manufacturing.

The company recently said it hopes to increase bulk production to up to 300,000 kg per year and have the ability to co-pack up to 2.5 million production products into the medicinal and recreational markets.

“We are open to and continue to look for those mutually beneficial partnerships,” Sudman said. “By working together, the industry can grow to new heights in terms of quality and profitability. We want to be that trusted partner that can drive product from the field to the store. I believe our record speaks for itself.”

Ayurcann provides a full line of services to its clients and partners from product formulation to packaging.

Contact the author Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK